Literature DB >> 2908268

Quantitative in-situ hybridization histochemistry studies on growth hormone (GH) gene expression in acromegalic somatotrophs: effects of somatostatin, GH-releasing factor and cortisol.

A Levy1, S L Lightman.   

Abstract

We have examined the effects of human GH-releasing factor (1-44) (GRF), cortisol and somatostatin-(1-14) on GH gene expression in solid tissue and dispersed cells from human pituitary adenomas using quantitative in-situ hybridization histochemistry. Sections cut from tissue obtained at hypophysectomy from three acromegalic patients were hybridized to probes directed against mature alpha-subunit, GH, prolactin, pro-opiomelanocortin, TSH beta-subunit and LH beta-subunit mRNA. Only one biopsy contained GH mRNA in isolation. A second was found to coexhibit GH, prolactin and alpha-subunit mRNA, and a third was found to contain prolactin, TSH beta-subunit, alpha-subunit and LH beta-subunit mRNA, with GH mRNA below the limit of specific detection, indicating that the sample was composed of normal rather than adenomatous pituitary tissue. GH mRNA in individual dispersed cells derived from the latter declined to barely detectable levels over 287 h, both in cultures containing GRF (10 ng/ml) or GRF (10 ng/ml) plus somatostatin (10 ng/ml) and in controls, but increased fourfold in cultures containing GRF (10 ng/ml) plus cortisol (0.5 mumol/l). GH mRNA remained unchanged in both adenoma samples over 138 and 450 h, irrespective of the addition of GRF or GRF plus hydrocortisone. In these samples, somatostatin plus GRF had no consistent effect. These studies confirm that quantitative in-situ hybridization histochemistry can be used to investigate hormone gene regulation in small samples of human tissue and should enable us to define more clearly the level at which abnormal gene regulation occurs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908268     DOI: 10.1677/jme.0.0010019

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  6 in total

1.  Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.

Authors:  E Thodou; G Kontogeorgos; E Kyrodimou; H Salla; L Ramyar; E Vamvassakis; G Piaditis; N Anagnostopoulos; S Tzanis; A Levedis; D Rologis; S L Asa
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.

Authors:  A Levy; S L Lightman
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

3.  Detection of growth hormone, prolactin and human beta-chorionic gonadotropin messenger RNA in growth-hormone-secreting pituitary adenomas by in situ hybridization.

Authors:  H Uhlig; W Saeger; S Fehr; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Octreotide Effect on Growth Hormone and Somatostatin Subtype 2 Receptor mRNAs of the Human Pituitary Somatotroph Adenomas.

Authors:  Lucia Stefaneanu; Kalman Kovacs; Kamal Thapar; Eva Horvath; Shlomo Melmed; Yona Greenman
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 5.  The effects of exercise on growth.

Authors:  K T Borer
Journal:  Sports Med       Date:  1995-12       Impact factor: 11.136

6.  Colocalization of growth hormone (GH) and glycoprotein subunit alpha in GH-producing pituitary adenomas in acromegalic patients.

Authors:  S Furuhata; T Kameya; T Tsuruta; H Naritaka; S Toya
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.